Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.
Also called NCT03199703
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 135 participants
- Sponsor
- Jason Andrade
- Registry
-
NCT03199703
-
- Other papers using this trial's data
- Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT03199703. Randomized; no masking; primary purpose treatment. Start 2017-01-17 (actual); primary completion 2019-05-17 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation
- Acronym
- CRYO-LATS
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Baylis transseptal system group
- Intervention (Device)
- Standard conventional transseptal group
- Lead sponsor
- Jason Andrade
- Collaborator
- Baylis Medical Company
Record details
- Record id
cardio:ct-nct03199703- Content hash
0da27baa9f9d0f06bbf443eb941f1f0493e668db39f04762a1988d2621a0332d